Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Assets (2016 - 2025)

Ptc Therapeutics has reported Return on Assets over the past 13 years, most recently at 0.2% for Q4 2025.

  • Quarterly results put Return on Assets at 0.2% for Q4 2025, up 2.0% from a year ago — trailing twelve months through Dec 2025 was 0.2% (up 2.0% YoY), and the annual figure for FY2025 was 0.24%, down 2.0%.
  • Return on Assets for Q4 2025 was 0.2% at Ptc Therapeutics, down from 0.27% in the prior quarter.
  • Over the last five years, Return on Assets for PTCT hit a ceiling of 0.27% in Q3 2025 and a floor of 0.52% in Q3 2023.
  • Median Return on Assets over the past 5 years was 0.03% (2022), compared with a mean of 0.08%.
  • Biggest five-year swings in Return on Assets: plummeted -49bps in 2023 and later skyrocketed 70bps in 2024.
  • Ptc Therapeutics' Return on Assets stood at 0.02% in 2021, then plummeted by -1866bps to 0.36% in 2022, then soared by 128bps to 0.1% in 2023, then tumbled by -319bps to 0.22% in 2024, then increased by 9bps to 0.2% in 2025.
  • The last three reported values for Return on Assets were 0.2% (Q4 2025), 0.27% (Q3 2025), and 0.23% (Q2 2025) per Business Quant data.